DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$8.720-0.250 (-2.787%)

Reaalajas hind

Healthcare
Biotehnoloogia
Prantsusmaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$8.970

Kõrge

$9.046

Madal

$8.720

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

252.2M

Tööstusharu

Biotehnoloogia

Riik

France

Kauplemisstatistika

Keskmine maht

0.44M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.441Praegune $8.720Kõrge $12.78

Seotud uudised

GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

Vaata rohkem
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

Vaata rohkem
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of

Vaata rohkem
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company (the

Vaata rohkem
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Analyst Upgrades

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies with a Market Outperform and raises the price target from $15 to $21.

Vaata rohkem
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.